Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
OtherLetters to the Editor

Advantage of Late Scanning in Brain 18F-FDG PET

Kazunari Ishii
Journal of Nuclear Medicine April 2006, 47 (4) 729;
Kazunari Ishii
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

TO THE EDITOR: I have read with great interest and enthusiasm the recent article by Chen et al. on the rapid scanning protocol for brain 18F-FDG PET (1). They found that rapid scanning for brain 18F-FDG PET is nearly equivalent to conventional scanning in the diagnosis of Alzheimer's disease. In their study, rapid scanning was performed later than conventional scanning after 18F-FDG injection, indicating the advantage of late scanning. Because the receiver-operating characteristic curves indicated that the area under the curve of rapid (late) scanning was slightly larger than that of conventional (early) scanning, their report supports our previous finding that late scanning is superior to early scanning in detecting hypometabolic regions in patients with Alzheimer's disease (2). I am also pleased that their study found regional 18F-FDG uptake differences between early and late scanning, verifying findings previously reported by my group (3). That is, relative 18F-FDG uptake in the posterior cingulate and parietal cortices, which are the regions affected in the Alzheimer's diseased brain, are larger at late scanning than at early scanning and 18F-FDG uptake in the cerebellum is lower at late scanning than at early scanning. We considered that these differences between the 2 sets of scans might have been related to regional differences in rate constants, such as K1, which indicates 18F-FDG transportation from plasma to tissue, and k3, which indicates phosphorylation of 18F-FDG (2). I expect this interesting brain physiology to be investigated further by using parametric mapping with compartment models.

References

  1. 1.↵
    Chen WP, Matsunari I, Noda A, et al. Rapid scanning protocol for brain 18F-FDG PET: a validation study. J Nucl Med. 2005;46:1633–1641.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Sakamoto S, Ishii K, Hosaka K, Mori T, Sasaki M, Mori E. Detectability of hypometabolic regions in mild Alzheimer disease: function of time after the injection of 2-[fluorine 18]-fluoro-2-deoxy-D-glucose. AJNR. 2005;26:843–847.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Ishii K, Sakamoto S, Hosaka K, Mori T, Sasaki M. Variation in FDG uptakes in different regions in normal human brain as a function of the time (30 and 60 minutes) after injection of FDG. Ann Nucl Med. 2002;16:299–301.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 47 (4)
Journal of Nuclear Medicine
Vol. 47, Issue 4
April 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Advantage of Late Scanning in Brain 18F-FDG PET
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Advantage of Late Scanning in Brain 18F-FDG PET
Kazunari Ishii
Journal of Nuclear Medicine Apr 2006, 47 (4) 729;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Advantage of Late Scanning in Brain 18F-FDG PET
Kazunari Ishii
Journal of Nuclear Medicine Apr 2006, 47 (4) 729;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Theranostic Digital Twins: An Indispensable Prerequisite for Personalized Cancer Care
  • Dosimetry in Radiopharmaceutical Therapy
  • Reply: Dosimetry in Radiopharmaceutical Therapy
Show more Letters to the Editor

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire